Unlock stock picks and a broker-level newsfeed that powers Wall Street.

OTC Markets EXMKT - Delayed Quote USD

NeutriSci International Inc. (NRXCF)

0.0013
0.0000
(0.00%)
At close: April 24 at 4:00:00 PM EDT
Loading Chart for NRXCF
  • Previous Close 0.0000
  • Open 0.0013
  • Bid --
  • Ask --
  • Day's Range 0.0013 - 0.0013
  • 52 Week Range 0.0013 - 0.0013
  • Volume 1,957
  • Avg. Volume 0
  • Market Cap (intraday) 653,980
  • Beta (5Y Monthly) 0.67
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

NeutriSci International Inc. develops and markets nutraceutical products in Canada, Germany, and Japan. It offers neuenergy, an energy tab designed to deliver enhanced focus and mental clarity. The company sells its products through a distribution network of retail storefront and online markets. NeutriSci International Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

www.neutrisci.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: NRXCF

View More

Performance Overview: NRXCF

Trailing total returns as of 4/24/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

NRXCF
0.00%
S&P/TSX Composite index (^GSPTSE)
0.43%

1-Year Return

NRXCF
0.00%
S&P/TSX Composite index (^GSPTSE)
13.05%

3-Year Return

NRXCF
0.00%
S&P/TSX Composite index (^GSPTSE)
16.71%

5-Year Return

NRXCF
95.94%
S&P/TSX Composite index (^GSPTSE)
71.48%

Compare To: NRXCF

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NRXCF

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -175.93%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    59.98k

  • Net Income Avi to Common (ttm)

    -552.45k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.33k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -105.91k

Research Analysis: NRXCF

View More

Company Insights: NRXCF

Research Reports: NRXCF

View More

People Also Watch